CME Activities

Please click the below image to begin our new Situation Room activity.

This Situation Room Activity is only compatible with Google Chrome and FireFox at this time. 

 

PODCAST

 

Oct
11
Tue
Approaching the Diagnosis and Treatment of Asthma
Oct 11 2022 @ 6:10 pm – Oct 11 2023 @ 7:10 pm

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

Approaching the Diagnosis and Treatment of Asthma

View Activity

FACULTY 

Patricia Vincent, RN
Care Consultant
Summit Medical Group
Elevance Health
Roselle, NJ

PROGRAM OVERVIEW

In this podcast episode we will review the clinical presentation and diagnostics of patients with asthma. In addition, to the management and monitoring of symptoms using patient-specific factors in the treatment of moderate-to-severe asthma.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Personalize the selection of add-on biologics using biomarkers, asthma phenotypes, and patient-specific factors.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Patricia Vincent, RN Reports no relevant relationships with a commercial entity or manufacturer.


CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date: October 7, 2022
Expiration Date: October 7, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Oct
12
Wed
Understanding Asthma Phenotypes and Endotypes
Oct 12 2022 @ 7:15 pm – Oct 12 2023 @ 8:15 pm

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

Understanding Asthma Phenotypes and Endotypes

View Activity

PROGRAM CHAIR

Nicola Hanania, MD, MS
Professor of Medicine
Director, Airways Clinical Research Center
Senator-at-Large, BCM Faculty Senate
Baylor College of Medicine
Houston, TX

PROGRAM OVERVIEW

In this podcast episode we will discuss the underlying characteristics of asthma and diagnostic tools available to help personalize the management of Asthma.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Utilize current treatment recommendations and emerging clinical trial data to develop evidence-based treatment plans that reduce exacerbation risks and oral corticosteroid use.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Relationship Manufacturer
 

 

Nicola Hanania, MD, MS

Consultant GlaxoSmithKline, Boehringer Ingelheim, Sanofi, Genentech, Novartis, Teva, and Amgen
Speakers Bureau Astra Zeneca and Sanofi
Research Funding Sanofi, Genentech, Novartis, GlaxoSmithKline, Astra Zeneca, and Boehringer Ingelheim

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose. 

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date:
October 7, 2022
Expiration Date: October 7, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Oct
13
Thu
Symptoms and Treatment of Severe Asthma
Oct 13 2022 @ 7:18 pm – Oct 13 2023 @ 8:18 pm

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

Symptoms and Treatment of Severe Asthma

View Activity

PROGRAM CHAIR

Nicola Hanania, MD, MS
Professor of Medicine
Director, Airways Clinical Research Center
Senator-at-Large, BCM Faculty Senate
Baylor College of Medicine
Houston, TX

PROGRAM OVERVIEW

In this podcast episode we will discuss asthma symptoms as they present in the various levels of disease severity and their effects on quality-of-life. Finally, we will review the use of biologic therapy in patients with severe symptoms – when to start, how to monitor, and adverse events to watch for.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Identify adult and pediatric patients who require intensified therapy to manage the symptoms and quality of life issues associated with uncontrolled moderate-to-severe asthma

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Relationship Manufacturer
 

 

Nicola Hanania, MD, MS

Consultant GlaxoSmithKline, Boehringer Ingelheim, Sanofi, Genentech, Novartis, Teva, and Amgen
Speakers Bureau Astra Zeneca and Sanofi
Research Funding Sanofi, Genentech, Novartis, GlaxoSmithKline, Astra Zeneca, and Boehringer Ingelheim

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose. 

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date:
October 7, 2022
Expiration Date: October 7, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Oct
14
Fri
Personalizing the Selection of Biologics for Moderate to Severe Asthma
Oct 14 2022 @ 7:21 pm – Oct 14 2023 @ 8:21 pm

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

Personalizing the Selection of Biologics for Moderate to Severe Asthma

View Activity

FACULTY

Sandra Adams, MD
Professor of Medicine
UT Health San Antonio
Deputy Chief of Pulmonary Diseases and Critical Care Medicine
South Texas Veterans Health Care System
San Antonio, Texas

PROGRAM OVERVIEW

In this podcast episode we will discuss the history of biologic therapy in asthma and how biomarkers may direct its treatment with these agents.  We will review the benefits and challenges of biologic therapy and review potential knowledge gaps regarding their use.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Personalize the selection of add-on biologics using biomarkers, asthma phenotypes, and patient-specific factors.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Relationship Manufacturer
 

Sandra Adams, MD

Research Funding and Principal Investigator AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sunovion
President and Founder WipeDiseases Foundation


CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose. 

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date:
October 7, 2022
Expiration Date: October 7, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Oct
15
Sat
Applying Treatment Recommendations to the Management of Asthma
Oct 15 2022 @ 7:23 pm – Oct 15 2023 @ 8:23 pm

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

Applying Treatment Recommendations to the Management of Asthma

View Activity

 Faculty

Sandra Adams, MD
Professor of Medicine
UT Health San Antonio
Deputy Chief of Pulmonary Diseases and Critical Care Medicine
South Texas Veterans Health Care System
San Antonio, Texas

PROGRAM OVERVIEW

In this podcast episode we will review the treatment therapies for the management of moderate – to – severe Asthma. In addition, review important factors to use when deciding to use biological therapies and best practices in management.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Utilize current treatment recommendations and emerging clinical trial data to develop evidence-based treatment plans that reduce exacerbation risks and oral corticosteroid use.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Relationship Manufacturer
 

Sandra Adams, MD

Research Funding and Principal Investigator AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sunovion
President and Founder WipeDiseases Foundation


CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose. 

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date:
October 7, 2022
Expiration Date: October 7, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Oct
16
Sun
The Patient’s Viewpoint: From Initial Diagnosis to Chronic Treatment
Oct 16 2022 @ 7:24 pm – Oct 16 2023 @ 8:24 pm

Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

The Patient’s Viewpoint: From Initial Diagnosis to Chronic Treatment

View Activity

GUEST

Valrie Brickley
Houston, TX

PROGRAM OVERVIEW

In this podcast episode we will hear from the patient’s perspective on how Asthma effects their quality of life. Their experience with asthma treatments and challenges for the newly diagnosed individual.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Identify adult and pediatric patients who require intensified therapy to manage the symptoms and quality of life issues associated with uncontrolled moderate-to-severe asthma

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of .33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: .33 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded .33 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

 Valrie Brickley  Reports no relevant relationships with a commercial entity or manufacturer.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose. 

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Release Date:
October 7, 2022
Expiration Date: October 7, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

 

Dec
8
Thu
Shady Grove Medical Center – Adventist Health
Dec 8 @ 12:30 pm – 1:30 pm

Time: 12:30 PM – 1:30 PM

Date: Thursday, December 8, 2022

Location: Rockville, MD

Dec
13
Tue
Goshen Health
Dec 13 @ 8:00 am – 9:00 am

Time: 8:00 AM – 9:00 AM

Date: Tuesday, December 13, 2022

Location: Goshen, IN

Dec
15
Thu
Family Medicine Residency Clinic
Dec 15 @ 1:00 pm – 2:00 pm

Time: 1:00 PM – 2:00 PM

Date: Thursday, December 15, 2022

Location: Abingdon, VA

Dec
7
Tue
Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes
Dec 7 2021 @ 5:13 pm – Dec 7 2022 @ 6:13 pm


Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes

View Activity

FACULTY

Diego J Maselli, MD, FCCP
Associate Professor of Medicine
Division of Pulmonary Diseases & Critical Care
University of Texas Health Science Center at San Antonio
Director, Severe Asthma Program
University Health System
San Antonio, TX

Nicola A Hanania, MD, MS, FCCP
Associate Professor of Medicine
Section of Pulmonary and Critical Care Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Houston, TX

PROGRAM OVERVIEW

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

TARGET AUDIENCE

This activity is designed to meet the needs of allergists, immunologists, and other healthcare providers involved in the care of patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

Upon the completion of this program, learners should be able to:

  • Utilize knowledge of the type 2 inflammatory pathway to select therapies that target the underlying chronic inflammation associated with severe asthma and other commonly comorbid conditions
  • Assess disease severity and identify patients who require step-up therapy to manage symptoms, minimize systemic steroid use and reduce emergency room visits
  • Design evidence-based treatment plans for pediatric and adult patients with moderate-to-severe asthma that include patient-specific factors, such as comorbidities, quality of life, and treatment responses

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: Education regarding the management of moderate-to-severe asthma leads to safe practices, quality care, and continued professional and personal development for nurses.

CNE Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIP
Diego J Maselli, MD reports that he has received consulting fees from Amgen, AstraZeneca, Genentech, GlaxoSmithKline, and Sanofi Regeneron. He serves on the speakers’ bureau for AstraZeneca, GlaxoSmithKline, and Sanofi Regeneron.

Nicola A Hanania, MD reports that he has received consulting fees from Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Sanofi, and Teva. He serves on the speakers’ bureau for AstraZeneca, Mylan, and Sanofi. He receives funding for contracted research from AstraZenca, Boehringer Ingelheim, Genentech, Gossamer Bio, GSK, Novartis, Sanofi, and Teva.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose

Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Chris Drury MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Ashley Whitehurst, Program Manager for Med Learning Group, has nothing to disclose.
Natalie Smith, Program Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the activity.
  3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected].

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASE DATE: December 07, 2021

EXPIRATION DATE: December 07, 2022

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

Nov
8
Tue
Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics
Nov 8 2022 @ 6:43 am – Nov 8 2023 @ 7:43 am



Personalizing the Management of Moderate-to-Severe Asthma in the Era of Biologics

View Activity

PROGRAM CHAIR

Nicola Hanania, MD, MS
Professor of Medicine

Director, Airways Clinical Research Center
Senator-at-Large, BCM Faculty Senate
Baylor College of Medicine
Houston, TX

PROGRAM OVERVIEW

This series will focus on the management of moderate-to-severe asthma.

TARGET AUDIENCE

This activity is intended for pulmonologists, allergists, immunologists, pediatricians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Identify adult and pediatric patients who require intensified therapy to manage the symptoms and quality of life issues associated with uncontrolled moderate-to-severe asthma.
  • Personalize the selection of add-on biologics using biomarkers, asthma phenotypes, and patient-specific factors.
  • Utilize current treatment recommendations and emerging clinical trial data to develop evidence-based treatment plans that reduce exacerbation risks and oral corticosteroid use.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating patients with asthma.

Credit: 1.0 ANCC Contact Hour

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Relationship Manufacturer
Nicola Hanania, MD, MS Consultant GlaxoSmithKline, Boehringer Ingelheim, Sanofi, Genentech, Novartis, Teva, and Amgen
Speakers Bureau Astra Zeneca and Sanofi
Research Funding Sanofi, Genentech, Novartis, GlaxoSmithKline, Astra Zeneca, and Boehringer Ingelheim

CME Content Review

The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff, Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Dave Chatman, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
  • Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
  • Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Submit the pre- and post-test and evaluation form to Med Learning Group

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity

 

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. These CME activities are planned and produced in accordance with the ACCME Essentials.